Hims & Hers Health HIMS
NYSE HIMS
$32.33 +1.24 (+4.00%)
At close: Aug 20, 2026 · 2:58 PM UTC

Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026)

Hims & Hers Health (HIMS) posted Shares Outstanding (Entity) of $230.7 million for Q1 2026, up 1.52% sequentially from $227.2 million in Q4 2025, and up 3.18% YoY from $223.6 million in Q1 2025.

Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $230.7 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 3.18% year-over-year to $230.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $230.7 million (up 3.18% YoY) and the FY2025 annual result came in at $227.2 million, up 2.9% from the prior year.
  • Shares Outstanding (Entity) climbed to $230.7 million in Q1 2026 per HIMS's latest filing, from $227.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $230.7 million in Q1 2026 and troughed at $205.9 million in Q1 2022.
  • A 5-year average of $216.4 million and a median of $214.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 34.49% in 2022, then increased 1.67% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $208.4 million in 2022, then increased by 2.42% to $213.5 million in 2023, then rose by 3.45% to $220.8 million in 2024, then climbed by 2.9% to $227.2 million in 2025, then increased by 1.52% to $230.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $230.7 million, $227.2 million, and $227.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - 832.44 Mn
10 Hims & Hers Health 7.49 Bn 6.65 Bn 480.80 Mn 231.75 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 231.75 Mn
Mar 31, 2026 228.36 Mn
Dec 31, 2025 224.96 Mn
Sep 30, 2025 226.35 Mn
Jun 30, 2025 224.37 Mn
Mar 31, 2025 221.99 Mn
Dec 31, 2024 215.94 Mn
Sep 30, 2024 216.62 Mn
Jun 30, 2024 214.62 Mn
Mar 31, 2024 213.45 Mn
Dec 31, 2023 209.34 Mn
Sep 30, 2023 210.13 Mn
Jun 30, 2023 208.42 Mn
Mar 31, 2023 207.14 Mn
Dec 31, 2022 204.52 Mn
Sep 30, 2022 205.23 Mn
Jun 30, 2022 203.95 Mn
Mar 31, 2022 202.70 Mn
Dec 31, 2021 186.78 Mn
Sep 30, 2021 200.04 Mn